Acadian Asset Management’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $436K | Buy |
540,565
+11,238
| +2% | +$9.06K | ﹤0.01% | 1166 |
|
|
2025
Q1 | $405K | Buy |
529,327
+43,946
| +9% | +$33.6K | ﹤0.01% | 1117 |
|
|
2024
Q4 | $617K | Buy |
485,381
+411,238
| +555% | +$523K | ﹤0.01% | 1032 |
|
|
2024
Q3 | $152K | Buy |
74,143
+52,033
| +235% | +$107K | ﹤0.01% | 1459 |
|
|
2024
Q2 | $83K | Hold |
22,110
| – | – | ﹤0.01% | 1559 |
|
|
2024
Q1 | $104K | Buy |
22,110
+6,615
| +43% | +$31.1K | ﹤0.01% | 1281 |
|
|
2023
Q4 | $65K | Buy |
15,495
+8,472
| +121% | +$35.5K | ﹤0.01% | 1428 |
|
|
2023
Q3 | $21K | Buy |
+7,023
| New | +$21K | ﹤0.01% | 1540 |
|